Answers are grounded in this paper and cite their sources.
Endothelin-1 (ET-1) is a multifunctional vasoactive peptide implicated in tumor proliferation, invasion, and angiogenesis. Although ET-1 expression has been reported in oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMDs), the magnitude and consistency of these associations remain unclear. We aim to systematically synthesize evidence on ET-1 levels in OSCC and OPMD compared with healthy controls. PubMed, Embase, CNKI, and Web of Science were searched up to April 30, 2026. Meta-analysis was performed using standardized mean difference (SMD). Heterogeneity was assessed with I 2 and Cochran Q tests. Publication bias was evaluated via funnel plots and Egger’s test. Study quality was evaluated using the Newcastle-Ottawa Scale (NOS). Eleven studies met the inclusion criteria; seven of these contributed quantitative saliva data to the meta-analysis, and four reported immunohistochemical (IHC) findings only. Patients with OSCC (Saliva: SMD = 1.76, 95% CI 0.77–2.75; I 2 = 89%) exhibited significantly higher ET-1 levels than healthy controls. Patients with OLP showed a pooled SMD of 0.31 (95% CI: -0.06–0.68; I 2 = 0%) and patients with OLK showed a pooled SMD of 1.42 (95% CI: 0.44–2.39 I 2 = 80%). IHC analysis showed significantly higher ET-1 positivity in OPMDs lesions and OSCC compared with normal mucosa; because the reported outcome metrics were not comparable, these findings were synthesized narratively. The level of salivary and serum ET-1 is significantly higher in OSCC than healthy control, suggesting that higher levels of ET-1 may be an important feature of OSCC. However, the evidence is limited by the small number of studies, very high heterogeneity, possible publication bias and very low certainty as assessed by GRADE, ET-1 should therefore be regarded as a hypothesis-generating candidate biomarker rather than a clinically validated test. More high-quality research is needed to verify these correlations and establish more reliable conclusions in the future.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: